A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy
NCT ID: NCT02096484
Last Updated: 2016-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2014-08-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD
NCT00426426
Metacognitive Therapy Versus Cognitive Behavioral Therapy for Mixed Anxiety Disorders: A Randomized Controlled Trial.
NCT01889342
Group-based Metacognitive Therapy for Burns and Plastics Patients
NCT04959916
Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care
NCT03621371
Mindfulness and Present Centered Therapies for PTSD: Efficacy and Mechanisms
NCT01347749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Metacognitive Therapy
Individuals randomly assigned to the metacognitive therapy group will undergo group metacognitive therapy for generalized anxiety disorder.. Individuals will undergo 8 sessions of group therapy lasting approximately 90 minutes.
Group Metacognitive Therapy
Mindfulness Meditation Therapy
Individuals randomly assigned to the mindfulness meditation therapy group will undergo group mindfulness meditation therapy for generalized anxiety disorder. Individuals will undergo 8 sessions of group therapy lasting approximately 90 minutes.
Mindfulness Meditation Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group Metacognitive Therapy
Mindfulness Meditation Therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* individuals who meet the DSM-IV (Diagnostic and Statistical Manual) criteria for generalized anxiety disorder
Exclusion Criteria
* Individuals who report suicidality
* Individuals with a brain injury or neurological insult
* Individual who currently engage in substance abuse
* Individuals with bipolar disorder
* Individuals with psychotic symptoms
* Individuals who cannot converse or read English
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adrian Wells
Professor of Clinical & Experimental Psychopathology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lora Capobianco
Role: PRINCIPAL_INVESTIGATOR
University of Manchester
James Thompson
Role: PRINCIPAL_INVESTIGATOR
University of Manchester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Rawnsley Building, Manchester Royal Infirmary, Oxford Road
Manchester, Lancashire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UM145073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.